Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin combined with Shouhui Tongbian capsule for dyslipidemia
ChiCTR2100043102Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rosuvastatin and shouhui tongbian in dyslipidemia (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Low-density lipoprotein cholesterol. Started Feb 2021; status: recruiting.
02
Drugs
rosuvastatinshouhui tongbian
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on ChiCTR2100043102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043102.